Increased Risk of Myocardial Infarction in Inclusion Body Myositis: A Non‐Concurrent Cohort Study
IBM is associated with increased risk of MI compared to population referents. Heightened cardiovascular monitoring and prevention strategies are needed in IBM.
Authors
- Jay Mandrekar
- Alanna M. Chamberlain (ORCID: https://orcid.org/0000-0003-1888-9584)
- William S. Harmsen (ORCID: https://orcid.org/0000-0001-7134-5362)
- Sara Muhammad
- Grayson Beecher (ORCID: https://orcid.org/0000-0003-3512-1796)
- Kathryn F. Larson (ORCID: https://orcid.org/0000-0003-2565-3318)
- Ibrahim Shammas (ORCID: https://orcid.org/0000-0002-1486-9722)
- Elie Naddaf (ORCID: https://orcid.org/0000-0001-6212-1236)
Institutions
- Mayo Clinic (US)
- University of Alberta (CA)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1111/ene.70177
- Citations
- 2
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Center for Clinical and Translational Science, Mayo Clinic
- Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston
- National Institute on Aging